The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients
about
Management of lower extremity peripheral arterial diseaseProgenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study.Comparison of walking performance over the first 2 minutes and the full 6 minutes of the Six-Minute Walk Test.Associations of calf skeletal muscle characteristics and peripheral nerve function with self-perceived physical functioning and walking ability in persons with peripheral artery disease.Walking economy before and after the onset of claudication pain in patients with peripheral arterial diseaseGreater endothelial apoptosis and oxidative stress in patients with peripheral artery diseaseBaseline lower extremity strength and subsequent decline in functional performance at 6-year follow-up in persons with lower extremity peripheral arterial diseaseCorridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial diseasePhysical activity during daily life and functional decline in peripheral arterial disease.Differences in presentation of symptoms between women and men with intermittent claudication.Six minute walk test in people with tuberculosis sequelaeSix Minute Walk Test to assess functional capacity in chronic liver disease patients.Gender differences in daily ambulatory activity patterns in patients with intermittent claudicationGender and racial differences in endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease.Change in dietary intake of adults with intermittent claudication undergoing a supervised exercise program and compared to matched controls.Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial.Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trialHow many steps/day are enough? For older adults and special populations.DIFFERENCES IN EXERCISE PERFORMANCE AND LEISURE-TIME PHYSICAL ACTIVITY IN OLDER CAUCASIANS AND AFRICAN-AMERICANSOxygen uptake before and after the onset of claudication during a 6-minute walk test.Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study).Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial diseaseLower extremity nerve function, calf skeletal muscle characteristics, and functional performance in peripheral arterial diseaseLeg symptom categories and rates of mobility decline in peripheral arterial diseaseTreadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trialUtility of the late life function and disability instrument as an outcome measure in patients participating in outpatient cardiac rehabilitation: a preliminary studyAssociation Between 6-Minute Walk Test and All-Cause Mortality, Coronary Heart Disease-Specific Mortality, and Incident Coronary Heart Disease.Optimal exercise program length for patients with claudication.Responsiveness and validity of the six-minute walk test in individuals with traumatic brain injury.Genomic and proteomic determinants of lower extremity revascularization failure: rationale and study designCalf muscle hemoglobin oxygen saturation in patients with peripheral artery disease who have different types of exertional leg pain.The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease.Effect of exercise training on clot strength in patients with peripheral artery disease and intermittent claudication: An ancillary studyPatterns of ambulatory activity in subjects with and without intermittent claudicationEffect of cognitive status on exercise performance and quality of life in patients with symptomatic peripheral artery diseaseINFLUENCE OF DIABETES ON AMBULATION AND INFLAMMATION IN MEN AND WOMEN WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASEAssessment of functional status and quality of life in claudication.Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial diseaseThe effect of metabolic syndrome components on exercise performance in patients with intermittent claudication.Prognostic value of functional performance for mortality in patients with peripheral artery disease.
P2860
Q24655017-8EFE2889-BC94-4A3D-81E1-6E03A261CC46Q30409726-E257EFE7-5C8A-49BC-A323-7E1EAEEF83EEQ33574597-94E7B549-958B-4ADE-B97B-B31C3FB9FF0CQ33667430-B77D2FEB-EEF7-49DF-92C9-AEEFC4668A60Q33741606-936F6C9F-B249-410A-AEFF-434D212768E8Q33745594-4F5696E1-2332-41F4-9365-571F2294FF19Q33904160-520B04FA-C7A0-457B-BAFA-4F0C898F7D22Q33911011-2D91EE27-4DF7-4B22-B4BB-4A75CE59061EQ33922705-5CBD7ED3-A518-41D3-B1FD-692C5237887EQ33947273-27D54263-8901-4E42-9E1C-641F197813EAQ34136778-90B4DA04-F367-424B-BCA7-5F59616AFCF1Q34224920-AB27C23F-7F03-4A08-B5FD-074BBA425F2EQ34283394-D8B75DF0-D192-4078-81D9-D2BEDFAB80EEQ34288235-CB3951F8-DFE7-45D1-8B3A-B1A2BB64941EQ34410301-84061B43-3FDA-44BC-BD5A-65E729ED536DQ34620003-19DFE76B-6B7A-4325-A878-ABC61CED62EFQ35070663-380A023C-BF81-48A1-B46C-20B3E7AF19A3Q35203653-24D38F43-169B-4BA4-867B-16D6E2580B36Q35347215-C2555B4C-602E-4D12-AA4F-3483DB654EA1Q35456920-615219E6-E6AD-4531-9B26-42115DF5D960Q35549044-066F0B2C-7B3C-41FD-B5BB-F68FE79EE239Q35568939-19CFE127-07DD-491E-ADFD-0672B8B24E6FQ35569776-8F723770-3BBB-41AD-9332-4F74617F670DQ35583621-696B09EF-BCBE-451B-BF72-055DA26828E3Q35706822-A7B034C5-6D7D-4D55-A34D-5EE830B9694CQ35760416-36C694E1-0EBD-4D66-B2F4-D1CF2FC8B26DQ35799782-01C3083D-A2D3-4FE1-B064-ECF7E0F5D1B2Q35923323-1E7D3AB5-87AC-4DB8-9D12-7B9F81C85C2BQ35937158-E9B46DEE-0522-4B13-958A-DB6AF9A12116Q35944843-FB41363E-44B8-4B49-9D8A-BA1A4FD08474Q35981596-05DDB5A0-97CC-465A-8A5A-827DA6ADBBABQ36274162-23275987-052A-4213-B6E2-CAF4028F40BEQ36372057-A6925C27-7674-4F7C-85E6-C1F39408A4D2Q36419677-9261F9BA-BF15-4B1E-8BC6-11693E3A5335Q36421157-46BE4988-CFAE-4043-BCAF-0D6010026D78Q36514230-7CCC3A4D-6A8D-496C-A391-A243D1023767Q36523317-A4DD8A63-1D39-4502-8545-61779397C584Q36676706-30FE8B4D-03BE-4CD0-90AD-A479FC6AA148Q36756293-D2EFD512-EA9F-46A2-9E07-ACAF8A9D18F1Q36761964-86F5CBBD-B988-43E1-96ED-ABCC2D26AA23
P2860
The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The clinical utility of a six- ...... ial occlusive disease patients
@ast
The clinical utility of a six- ...... ial occlusive disease patients
@en
The clinical utility of a six- ...... ial occlusive disease patients
@nl
type
label
The clinical utility of a six- ...... ial occlusive disease patients
@ast
The clinical utility of a six- ...... ial occlusive disease patients
@en
The clinical utility of a six- ...... ial occlusive disease patients
@nl
prefLabel
The clinical utility of a six- ...... ial occlusive disease patients
@ast
The clinical utility of a six- ...... ial occlusive disease patients
@en
The clinical utility of a six- ...... ial occlusive disease patients
@nl
P1476
The clinical utility of a six- ...... ial occlusive disease patients
@en
P2093
A W Gardner
P S Montgomery
P304
P356
10.1111/J.1532-5415.1998.TB03804.X
P407
P577
1998-06-01T00:00:00Z